Equity Profile

GEHC

GE HealthCare Technologies Inc.

Health CareHealth Care Equipment$29.7B

Apr29Wed

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:20 AM EDT

GE HealthCare Technologies Misses on EPS, Stock Up 0.00%

Metric	Actual	Expected	Surprise
EPS	$0.99	$1.05	-7.04%
Revenue	N/A	$5.0B	N/A

management commentary, guidance changes, and full analysis available with Pro.

GE HealthCare Technologies Misses on EPS, Stock Up 0.00%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.99	$1.05	-7.04%
Revenue	N/A	$5.0B	N/A

Management Commentary

Tone: Cautiously Optimistic

Management expressed cautious optimism about future growth despite missing EPS expectations. They highlighted their commitment to innovation and operational improvements.

Management acknowledged the challenging market conditions affecting earnings.

They emphasized ongoing investments in innovation and efficiency.

What It Means

GE HealthCare's earnings report shows a miss on EPS expectations, which may raise concerns among investors about profitability. However, the stock reaction remained unchanged at 0.00%, indicating that investors may have anticipated the results. The lack of revenue data and guidance leaves some uncertainty about future performance, but management's focus on innovation suggests they are looking to improve in the long run.

Company Snapshot

GE HealthCare Technologies Inc. operates in the health care sector, focusing on medical equipment and technology....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

$1.05

Revenue

Total revenue reflects the company's ability to generate sales and is vital for assessing growth potential.

$5.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

GE HealthCare Technologies Inc. operates in the health care sector, focusing on medical equipment and technology. With a market cap of $31 billion, the company plays a crucial role in providing innovative solutions that enhance patient care and streamline healthcare processes.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+6.05%

Avg Stock Reaction

-0.23%

Last Quarter Recap

In Q4-2025, GE HealthCare reported an EPS of $1.44, slightly above estimates, which led to a positive stock reaction of nearly 5% the following day. However, revenue figures were not disclosed.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect GE HealthCare to report solid earnings in Q1-2026, with a consensus EPS of $1.05 and revenue of $5.0 billion. The company has consistently beaten EPS estimates in previous quarters.

Bull Case

If GE HealthCare continues its trend of beating earnings expectations, it could see a significant stock price increase, reflecting strong operational performance and market confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in stock price, especially given the historical volatility around earnings reports.

Key Metrics to Watch

EPS

$1.05

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$5.0B

Total revenue reflects the company's ability to generate sales and is vital for assessing growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will GE HealthCare's EPS exceed the consensus estimate of $1.05?

A beat on EPS would reinforce the company's strong performance and could lead to a positive market reaction.

What guidance will management provide regarding revenue growth?

Investors will closely watch for any forward-looking statements that could impact future performance and stock valuation.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate GE HealthCare's ability to leverage recent technological advancements in medical equipment, leading to higher-than-expected revenue growth.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating stronger operational efficiency than anticipated.

Options pricing suggests a significant move is expected, reflecting uncertainty that may not be fully captured in current estimates.

Key Risk

If revenue growth exceeds $5.1 billion, it could challenge the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will determine if the company can maintain its growth trajectory amid market uncertainties.

Bull Confirmed If

An EPS of $1.07 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $0.96 would support the bear case, suggesting potential operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±6.12%

Historical Avg

±5.6%

In line with history

The options market is pricing in a potential stock movement of over 6% following the earnings report, indicating uncertainty among investors.

Options are pricing ±6.1% while GEHC has averaged ±5.6% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.8%

30d HV

32.7%

Calls (272K)P/C Ratio: 0.64Puts (152K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 9 of 23 (39%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 23 (61%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 6.3%, with a raw directional average of +2.4% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If GE HealthCare beats expectations, history suggests a potential stock increase of around 2.4%, confirming strong operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.

Miss

A miss on earnings could lead to a decline in stock price, with historical averages indicating a potential drop of around 5.8%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·2 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

D-ALTerri A. SewellRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or technological advancements.
2Management's commentary on market demand and competitive landscape.
3Insights into cost management strategies and their impact on margins.
4Guidance on future revenue growth and market expansion plans.
5Responses to analyst questions regarding potential risks and challenges.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Apr27

OMABReported

Grupo Aeroportuario del Centro Norte, S.A.B. de C.V.

RecapView

Apr27

PIIReported

Company Snapshot

GE HealthCare Technologies Inc. operates in the health care sector, focusing on medical equipment and technology....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

$1.05

Revenue

Total revenue reflects the company's ability to generate sales and is vital for assessing growth potential.

$5.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+6.05%

Avg Stock Reaction

-0.23%

Last Quarter Recap

In Q4-2025, GE HealthCare reported an EPS of $1.44, slightly above estimates, which led to a positive stock reaction of nearly 5% the following day. However, revenue figures were not disclosed.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect GE HealthCare to report solid earnings in Q1-2026, with a consensus EPS of $1.05 and revenue of $5.0 billion. The company has consistently beaten EPS estimates in previous quarters.

Bull Case

If GE HealthCare continues its trend of beating earnings expectations, it could see a significant stock price increase, reflecting strong operational performance and market confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in stock price, especially given the historical volatility around earnings reports.

Key Metrics to Watch

EPS

$1.05

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$5.0B

Total revenue reflects the company's ability to generate sales and is vital for assessing growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will GE HealthCare's EPS exceed the consensus estimate of $1.05?

A beat on EPS would reinforce the company's strong performance and could lead to a positive market reaction.

What guidance will management provide regarding revenue growth?

Investors will closely watch for any forward-looking statements that could impact future performance and stock valuation.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate GE HealthCare's ability to leverage recent technological advancements in medical equipment, leading to higher-than-expected revenue growth.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating stronger operational efficiency than anticipated.

Options pricing suggests a significant move is expected, reflecting uncertainty that may not be fully captured in current estimates.

Key Risk

If revenue growth exceeds $5.1 billion, it could challenge the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will determine if the company can maintain its growth trajectory amid market uncertainties.

Bull Confirmed If

An EPS of $1.07 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $0.96 would support the bear case, suggesting potential operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±6.12%

Historical Avg

±5.6%

In line with history

The options market is pricing in a potential stock movement of over 6% following the earnings report, indicating uncertainty among investors.

Options are pricing ±6.1% while GEHC has averaged ±5.6% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.8%

30d HV

32.7%

Calls (272K)P/C Ratio: 0.64Puts (152K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 9 of 23 (39%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If GE HealthCare beats expectations, history suggests a potential stock increase of around 2.4%, confirming strong operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.

Miss

A miss on earnings could lead to a decline in stock price, with historical averages indicating a potential drop of around 5.8%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·2 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

D-ALTerri A. SewellRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or technological advancements.
2Management's commentary on market demand and competitive landscape.
3Insights into cost management strategies and their impact on margins.
4Guidance on future revenue growth and market expansion plans.
5Responses to analyst questions regarding potential risks and challenges.